PaulFrancisLewisMD

PubMed

• Mycobacterium chelonae Facial Infections Following Injection of Dermal Filler.
  Rodriguez, J. M.,Xie, Y. L.,Winthrop, K. L.,Schafer, S.,Sehdev, P.,Solomon, J.,Jensen, B.,Toney, N. C.,Lewis, P. F.> ;Aesthet Surg J. 2013 Feb
• A community-based outbreak of severe respiratory illness caused by human adenovirus serotype 14.
  Lewis, P.F., Schmidt, M.A., Lu, X., Erdman, D.D., Campbell, M., Thomas, A., Cieslak, P.R., Grenz, L.D., Tsaknardis, L., Gleaves, C., Kendall, B., Gilbert, D.> ;J Infect Dis. 2009-05-15
• Evidence that low-level viremias during effective highly active antiretroviral therapy result from two processes: expression of archival virus and replication of virus.
  Tobin, N. H.,Learn, G. H.,Holte, S. E.,Wang, Y.,Melvin, A. J.,McKernan, J. L.,Pawluk, D. M.,Mohan, K. M.,Lewis, P. F.,Mullins, J. I.,Frenkel, L. M.> ;J Virol. 2005 Aug
• Multiple viral genetic analyses detect low-level human immunodeficiency virus type 1 replication during effective highly active antiretroviral therapy.
  Frenkel, L.M., Wang, Y., Learn, G.H., McKernan, J.L., Ellis, G.M., Mohan, K.M., Holte, S.E., De Vange, S.M., Pawluk, D.M., Melvin, A.J., Lewis, P.F., Heath, L.M., Beck...> ;J Virol. 2003 May
• Efficacy and toxicity of antiretroviral therapy using 4 or more agents: application of a strategy for antiretroviral management in human immunodeficiency virus-infecte...
  Melvin, A.J., Lewis, P.F., Mohan, K.M., Naugler, W.S., Frenkel, L.M.> ;Arch Pediatr Adolesc Med. 2002 Jun
• Join now to see all